As of November 2024, SK Biopharmaceuticals has a market cap of $6.16B. This makes SK Biopharmaceuticals the world's 2376th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $5.04B | -14.94% |
2023 | $5.93B | 39.25% |
2022 | $4.26B | -25.82% |
2021 | $5.74B | -42.49% |
2020 | $9.98B | - |